ZBH
ZIMMER BIOMET HOLDINGS, INC.
$87.27
-0.07%
$16.9B
No data for this timeframe.
Vol
Market Cap$16.9B
Cap SizeLarge Cap
Analyst ConsensusHold (35%)
Inst. Holders14 funds
Inst. Value$5.0B
Inst. Activity2 buys / 2 sells
Insider Activity0B / 2S
Insider Net $-$597.9K
SEC Reports5
Exchange NYSE·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. DE·CIK 0001136869·Prev Close $87.33
Recent Activity
Jun 9, 2026
short_volume
Short Volume: ZBH — 60.1% short (0.5M / 0.8M)
Short: 459,922 | Exempt: 108 | TRF Vol: 765,564 | Short Ratio: 60.1% | Off-exchange volume (dark poo
Jun 1, 2026
Insider
Noor Jehanzeb sold 1,857 shares
See remarks below. @ $0.00 ($0.00)
May 29, 2026
Insider
Yi Sang sold 4,200 shares
Group President, Asia Pacific @ $82.64 ($347.1K)
May 22, 2026
Insider
Jafry Syed A. sold 875.35 shares
Director @ $0.00 ($0.00)
May 12, 2026
SEC
Zimmer Biomet announced an increased share repurchase expectation for FY2026, now targeting up to $1.0 billion in buybac
8-K — Impact 4/10
May 1, 2026
SEC
Delaware Chancery Court partially granted Zimmer Biomet's motion to dismiss in an earnout dispute from its acquisition o
COURT-RULING — Impact 3/10
Apr 28, 2026
SEC
Zimmer Biomet CFO Suketu Upadhyay resigned effective April 28, 2026 to pursue a new opportunity; Controller Paul Stellat
8-K — Impact 3/10
Inst.
NORGES BANK — NEW
2,460,348 shares ($221.2M)
Price Targets
$98.70
+10.1% upside
Buy
Current $89.63
Low $83.00
Median $94.00
High $130.00
20 analysts
$83.00
$130.00
Analyst Ratings
4Strong Buy
8Buy
20Hold
2Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 28, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
| Apr 29, 2026 | JP Morgan | MAINTAIN | Neutral → Neutral |
| Apr 29, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
| Apr 29, 2026 | Citizens | MAINTAIN | Market Outperform → Market Outperform |
| Apr 29, 2026 | Wells Fargo | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $2.01 | $1.98 — $2.05 | -3% YoY | 23 |
| Next Q | $1.88 | $1.85 — $1.93 | -1% YoY | 23 |
| Current FY | $8.48 | $8.35 — $8.53 | 3% YoY | 26 |
| Next FY | $9.00 | $8.61 — $9.73 | 6% YoY | 26 |
Latest Reports
NEUTRAL
8-K
4/10
Zimmer Biomet announced an increased share repurchase expectation for FY2026, now targeting up to $1.0 billion in buybac
May 12, 2026
NEUTRAL
COURT-RULING
3/10
Delaware Chancery Court partially granted Zimmer Biomet's motion to dismiss in an earnout dispute from its acquisition o
May 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| DODGE & COX | $2.1B | — |
| VANGUARD GROUP INC | $2.1B | — |
| NORGES BANK | $221.2M | NEW |
| MORGAN STANLEY | $165.3M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $118.1M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Noor Jehanzeb | A | $0.00 |
| May 29, 2026 | Yi Sang | SELL | $347.1K |
| May 22, 2026 | Jafry Syed | A | $0.00 |
| May 22, 2026 | Jafry Syed | A | $0.00 |
| May 22, 2026 | HAGEMANN ROBERT | A | $0.00 |
14 institutional holders with $5.0B total value (55,955,791 shares) as of 2025-Q4. Top holders: DODGE, VANGUARD, NORGES.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | DODGE & COX | 23,506,849 | $2.1B | 42.1% | — |
| 2 | VANGUARD GROUP INC | 23,483,741 | $2.1B | 42.0% | — |
| 3 | NORGES BANK | 2,460,348 | $221.2M | 4.4% | NEW |
| 4 | MORGAN STANLEY | 1,838,096 | $165.3M | 3.3% | — |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,312,911 | $118.1M | 2.3% | NEW |
| 6 | BANK OF AMERICA CORP /DE/ | 1,300,615 | $117.0M | 2.3% | — |
| 7 | SOUND SHORE MANAGEMENT INC /CT/ | 850,757 | $76.5M | 1.5% | NEW |
| 8 | CAUSEWAY CAPITAL MANAGEMENT LLC | 728,498 | $65.5M | 1.3% | ADD +25.2% |
| 9 | WELLS FARGO & COMPANY/MN | 224,089 | $20.2M | 0.4% | TRIM -26.1% |
| 10 | FMR LLC | 115,488 | $10.4M | 0.2% | TRIM -41.6% |
| 11 | Hillman Capital Management, Inc. | 45,969 | $4.1M | 0.1% | TRIM -25.8% |
| 12 | ARIEL INVESTMENTS, LLC | 3,229 | $290.4K | 0.0% | NEAR_EXIT -99.2% |
| 13 | TWO SIGMA INVESTMENTS, LP | 3,201 | $287.8K | 0.0% | NEW |
| 14 | Olstein Capital Management, L.P. | 82,000 | $7.4K | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 2,460,348 | — | $221.2M | 2025-Q4 |
| CAUSEWAY CAPITAL MANAGEMENT LLC | ADD | 581,779 | 728,498 | +25.2% | $65.5M | 2025-Q4 |
| ARIEL INVESTMENTS, LLC | NEAR_EXIT | 394,715 | 3,229 | -99.2% | $290.4K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 121,800 | 0 | -100.0% | $0.00 | 2025-Q4 |
| ARIEL INVESTMENTS, LLC | ADD | 253,190 | 394,715 | +55.9% | $38.9M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 121,800 | — | $12.0M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 3,393 | — | $334.2K | 2025-Q3 |
| NORGES BANK | EXIT | 2,476,344 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 2,476,344 | — | $225.9M | 2025-Q2 |
| UBS Group AG | ADD | 817,552 | 1,129,265 | +38.1% | $103.0M | 2025-Q2 |
| CAUSEWAY CAPITAL MANAGEMENT LLC | TRIM | 805,509 | 578,238 | -28.2% | $52.7M | 2025-Q2 |
| FMR LLC | TRIM | 206,078 | 120,359 | -41.6% | $11.0M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 30,400 | 0 | -100.0% | $0.00 | 2025-Q2 |
| UBS Group AG | ADD | 633,010 | 817,552 | +29.2% | $92.5M | 2025-Q1 |
| FMR LLC | NEAR_EXIT | 1,438,011 | 206,078 | -85.7% | $23.3M | 2025-Q1 |
| Hillman Capital Management, Inc. | TRIM | 78,939 | 58,557 | -25.8% | $6.6M | 2025-Q1 |
| NORGES BANK | EXIT | 2,046,987 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 759,978 | 2,677,620 | +252.3% | $282.8M | 2024-Q4 |
| SOUND SHORE MANAGEMENT INC /CT/ | NEW | — | 771,063 | — | $81.4M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 265,550 | 196,189 | -26.1% | $20.7M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 153,300 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 1,211,001 | — | $130.7M | 2024-Q3 |
17 unique insiders with 2 transactions. Net insider value: -$597.9K ($0.00 bought, $597.9K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Noor Jehanzeb | See remarks below. | A | 1,857 | $0.00 | $0.00 |
| May 29, 2026 | Yi Sang | Group President, Asia Pacific | SELL | 4,200 | $82.64 | $347.1K |
| May 22, 2026 | Jafry Syed A. | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | Jafry Syed A. | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | HAGEMANN ROBERT | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | HIGGINS ARTHUR J | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | HAGEMANN ROBERT | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | HIGGINS ARTHUR J | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | Shapiro Louis | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | Kolli Sreelakshmi | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | Kolli Sreelakshmi | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | Kurdikar Devdatt | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | Kurdikar Devdatt | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | Shapiro Louis | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | BERNARD BETSY J | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | BERNARD BETSY J | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | Hilado Maria Teresa | Director | A | 875.35 | $0.00 | $0.00 |
| May 22, 2026 | Hilado Maria Teresa | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | Farrell Michael J. | Director | A | 1,517.274 | $0.00 | $0.00 |
| May 22, 2026 | Farrell Michael J. | Director | A | 875.35 | $0.00 | $0.00 |
| Apr 1, 2026 | Noor Jehanzeb | See remarks below. | M | 6,626 | $0.00 | $0.00 |
| Apr 1, 2026 | Noor Jehanzeb | See remarks below. | M | 6,626 | $0.00 | $0.00 |
| Apr 1, 2026 | Noor Jehanzeb | See remarks below. | F | 1,677 | $90.67 | $152.1K |
| Mar 31, 2026 | Farrell Michael J. | Director | A | 420.97 | $0.00 | $0.00 |
| Mar 31, 2026 | Kurdikar Devdatt | Director | A | 154.356 | $0.00 | $0.00 |
| Mar 31, 2026 | HAGEMANN ROBERT | Director | A | 308.711 | $0.00 | $0.00 |
| Mar 31, 2026 | Shapiro Louis | Director | A | 154.356 | $0.00 | $0.00 |
| Mar 31, 2026 | Kolli Sreelakshmi | Director | A | 175.404 | $0.00 | $0.00 |
| Mar 31, 2026 | HIGGINS ARTHUR J | Director | A | 308.711 | $0.00 | $0.00 |
| Mar 31, 2026 | Hilado Maria Teresa | Director | A | 378.873 | $0.00 | $0.00 |
| Mar 31, 2026 | Jafry Syed A. | Director | A | 182.421 | $0.00 | $0.00 |
| Mar 12, 2026 | Winkler Lori | SVP and CHRO | SELL | 2,650 | $94.66 | $250.8K |
| Mar 6, 2026 | Yi Sang | Group President, Asia Pacific | M | 7,050 | $0.00 | $0.00 |
| Mar 6, 2026 | Tornos Ivan | Chairman, President and CEO | M | 24,436 | $0.00 | $0.00 |
| Mar 6, 2026 | Phipps Chad F | See remarks below. | F | 1,889 | $92.54 | $174.8K |
| Mar 6, 2026 | Stellato Paul A | VP, Controller, CAO | M | 1,363 | $0.00 | $0.00 |
| Mar 6, 2026 | Phipps Chad F | See remarks below. | M | 4,692 | $0.00 | $0.00 |
| Mar 6, 2026 | Phipps Chad F | See remarks below. | M | 4,692 | $0.00 | $0.00 |
| Mar 6, 2026 | Stellato Paul A | VP, Controller, CAO | F | 633 | $92.54 | $58.6K |
| Mar 6, 2026 | Stellato Paul A | VP, Controller, CAO | M | 1,363 | $0.00 | $0.00 |
| Mar 6, 2026 | Yi Sang | Group President, Asia Pacific | M | 7,050 | $0.00 | $0.00 |
| Mar 6, 2026 | Winkler Lori | SVP and CHRO | M | 3,935 | $0.00 | $0.00 |
| Mar 6, 2026 | VAN ZUILEN WILFRED | Group Pres, EMEA | F | 1,260 | $92.54 | $116.6K |
| Mar 6, 2026 | VAN ZUILEN WILFRED | Group Pres, EMEA | M | 4,843 | $0.00 | $0.00 |
| Mar 6, 2026 | Upadhyay Suketu | Exec VP, CFO | M | 10,217 | $0.00 | $0.00 |
| Mar 6, 2026 | Upadhyay Suketu | Exec VP, CFO | M | 10,217 | $0.00 | $0.00 |
| Mar 6, 2026 | Upadhyay Suketu | Exec VP, CFO | F | 4,547 | $92.54 | $420.8K |
| Mar 6, 2026 | VAN ZUILEN WILFRED | Group Pres, EMEA | M | 4,843 | $0.00 | $0.00 |
| Mar 6, 2026 | Winkler Lori | SVP and CHRO | M | 3,935 | $0.00 | $0.00 |
| Mar 6, 2026 | Winkler Lori | SVP and CHRO | F | 1,549 | $92.54 | $143.3K |
5 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 4.2/10.
NEUTRAL
8-K
4/10
Zimmer Biomet announced an increased share repurchase expectation for FY2026, now targeting up to $1
May 12, 2026
NEUTRAL
COURT-RULING
3/10
Delaware Chancery Court partially granted Zimmer Biomet's motion to dismiss in an earnout dispute fr
May 1, 2026
NEUTRAL
8-K
3/10
Zimmer Biomet CFO Suketu Upadhyay resigned effective April 28, 2026 to pursue a new opportunity; Con
Apr 28, 2026
BULLISH
8-K
8/10
Zimmer Biomet reported Q1 2026 adjusted EPS of $2.09, beating consensus of $1.86 by 12.4%, on revenu
Apr 28, 2026
NEUTRAL
DEFA14A
3/10
Zimmer Biomet Holdings, Inc. (ZBH) filed a definitive proxy statement (DEFA14A) for its 2026 Annual
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Sell (35% buy). Based on 34 analysts: 4 strong buy, 8 buy, 20 hold, 2 sell, 0 strong sell.
Analyst Price Targets
$98.70 mean target
+10.1% upside
Buy (2.54)
$83.00 Low
$130.00 High
| Metric | Value |
|---|---|
| Current Price | $89.63 |
| Target Low | $83.00 |
| Target Mean | $98.70 |
| Target Median | $94.00 |
| Target High | $130.00 |
| # Analysts | 20 |
| Recommendation | Buy (2.54) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$2.01 | $1.98 | $2.05 | -2.8% | -0.0% | 1↑ 19↓ | $2.1B | 2.8% | 23 |
| Next Q 2026-09-30 |
$1.88 | $1.85 | $1.93 | -1.2% | -0.1% | 0↑ 21↓ | $2.0B | 1.9% | 23 |
| Current FY 2026-12-31 |
$8.48 | $8.35 | $8.53 | 3.4% | +0.1% | 6↑ 1↓ | $8.5B | 3.8% | 26 |
| Next FY 2027-12-31 |
$9.00 | $8.61 | $9.73 | 6.2% | +0.1% | 9↑ 4↓ | $8.8B | 3.5% | 26 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $2.012 | |
| 7d ago | $2.011 | +0.001 |
| 30d ago | $2.012 | -0.000 |
| 60d ago | $2.045 | -0.034 |
| 90d ago | $2.047 | -0.035 |
14 analyst firms have rated this stock: 1 upgrades, 2 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 28, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Apr 29, 2026 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Apr 29, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Apr 29, 2026 | Citizens | MAINTAIN | Market Outperform | Market Outperform |
| Apr 29, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 29, 2026 | Barclays | MAINTAIN | Underweight | Underweight |
| Apr 29, 2026 | Truist Securities | REITERATE | Hold | Hold |
| Apr 29, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Apr 13, 2026 | Leerink Partners | INITIATE | — | Market Perform |
| Mar 23, 2026 | BTIG | DOWNGRADE | Buy | Neutral |
| Feb 12, 2026 | Barclays | MAINTAIN | Underweight | Underweight |
| Feb 11, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Feb 11, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 10, 2026 | BTIG | REITERATE | Buy | Buy |
| Feb 10, 2026 | Needham | REITERATE | Hold | Hold |
| Jan 28, 2026 | UBS | MAINTAIN | Sell | Sell |
| Jan 9, 2026 | Bernstein | MAINTAIN | Market Perform | Market Perform |
| Jan 8, 2026 | BTIG | REITERATE | Buy | Buy |
| Jan 5, 2026 | Evercore ISI Group | UPGRADE | In-Line | Outperform |
| Dec 16, 2025 | Baird | DOWNGRADE | Outperform | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 8 | 20 | 2 | 0 | 35% | |
| May 1, 2026 | 3 | 8 | 21 | 3 | 0 | 31% | |
| Apr 1, 2026 | 3 | 8 | 20 | 3 | 0 | 32% | |
| Mar 1, 2026 | 4 | 8 | 20 | 3 | 0 | 34% | |
| Feb 1, 2026 | 4 | 8 | 19 | 3 | 0 | 35% | |
| Jan 1, 2026 | 4 | 7 | 20 | 2 | 0 | 33% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 9, 2026
short_volume
Short Volume: ZBH — 60.1% short (0.5M / 0.8M)
Short: 459,922 | Exempt: 108 | TRF Vol: 765,564 | Short Ratio: 60.1% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
short_volume
Short Volume: ZBH — 73.2% short (0.4M / 0.6M)
Short: 448,569 | Exempt: 6 | TRF Vol: 612,587 | Short Ratio: 73.2% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: ZBH — 58.8% short (0.4M / 0.7M)
Short: 396,334 | Exempt: 0 | TRF Vol: 673,645 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
short_volume
Short Volume: ZBH — 67.8% short (0.4M / 0.6M)
Short: 422,107 | Exempt: 0 | TRF Vol: 622,274 | Short Ratio: 67.8% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: ZBH — 74.6% short (0.5M / 0.6M)
Short: 476,979 | Exempt: 211 | TRF Vol: 639,068 | Short Ratio: 74.6% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: ZBH — 65.9% short (0.6M / 1.0M)
Short: 629,550 | Exempt: 629 | TRF Vol: 955,260 | Short Ratio: 65.9% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: ZBH — 67.6% short (0.5M / 0.7M)
Short: 500,608 | Exempt: 383 | TRF Vol: 740,429 | Short Ratio: 67.6% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: ZBH — 58.4% short (0.4M / 0.7M)
Short: 430,962 | Exempt: 377 | TRF Vol: 738,079 | Short Ratio: 58.4% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: ZBH — 58.0% short (0.4M / 0.6M)
Short: 368,564 | Exempt: 1 | TRF Vol: 635,056 | Short Ratio: 58.0% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: ZBH — 68.7% short (0.8M / 1.1M)
Short: 767,479 | Exempt: 238 | TRF Vol: 1,117,672 | Short Ratio: 68.7% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: ZBH — 57.0% short (0.7M / 1.3M)
Short: 736,966 | Exempt: 251 | TRF Vol: 1,292,431 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: ZBH — 59.9% short (0.6M / 1.1M)
Short: 641,234 | Exempt: 1,379 | TRF Vol: 1,070,077 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: ZBH — 3.2M shares, 62,520 trades
Week starting 2026-05-18. Total ATS volume: 3,239,771 shares across 62,520 trades.
May 15, 2026
short_volume
Short Volume: ZBH — 66.5% short (0.7M / 1.0M)
Short: 664,398 | Exempt: 0 | TRF Vol: 998,392 | Short Ratio: 66.5% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_volume
Short Volume: ZBH — 65.5% short (0.6M / 0.9M)
Short: 616,673 | Exempt: 0 | TRF Vol: 940,863 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
May 1, 2026
Enforcement
Timothy H. Meyers v. Zimmer Biomet Holdings, Inc. and Embody, Inc.
Court ruling from Court of Chancery of Delaware. Docket: C.A. No. 2025-0732-BWD